SOPHiA GENETICS to Participate in Upcoming November Investor Conferences
November 04 2022 - 6:49AM
SOPHiA GENETICS SA (Nasdaq: SOPH), a cloud-native software company
in the healthcare space, announced today the company will be
participating in the following investor conferences.
- Evercore ISI HealthCONx Virtual Conference; Fireside Chat on
Tuesday, November 29 at 2:15pm EST / 8:15pm CET
- Credit Suisse 26th Annual Technology Conference in Scottsdale,
AZ; Fireside Chat on Wednesday, November 30 at 1:40pm MST / 9:40pm
CET
Interested parties may access live and archived webcasts of the
sessions on the Investor Relations section of the company website
at ir.sophiagenetics.com.
About SOPHiA GENETICSSOPHiA GENETICS (Nasdaq:
SOPH) is a software company dedicated to establishing the practice
of data-driven medicine as the standard of care and for life
sciences research. It is the creator of the SOPHiA DDMâ„¢ Platform, a
cloud-native platform capable of analyzing data and generating
insights from complex multimodal data sets and different diagnostic
modalities. The SOPHiA DDMâ„¢ Platform and related solutions,
products and services are currently used by a broad network of
hospital, laboratory, and biopharma institutions globally. For more
information, visit SOPHiAGENETICS.COM, or connect
on Twitter, LinkedIn, Facebook, and Instagram. Where
others see data, we see answers.
Investor Contact:Jennifer PottageHead of
Investor Relationsir@sophiagenetics.com
Media Contact:Kelly KatapodisSenior Manager,
Media & Communicationsmedia@sophiagenetics.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Oct 2023 to Oct 2024